12 Health Care Stocks Moving In Thursday's Pre-Market Session

Loading...
Loading...

Gainers

  • Neoleukin Therapeutics NLTX stock moved upwards by 32.4% to $0.7 during Thursday's pre-market session. The company's market cap stands at $29.9 million.
  • Biophytis BPTS shares increased by 28.02% to $0.64. The market value of their outstanding shares is at $13.0 million.
  • First Wave BioPharma FWBI shares increased by 26.75% to $4.5. The company's market cap stands at $4.4 million.
  • Macrogenics MGNX shares moved upwards by 18.18% to $6.5. The company's market cap stands at $399.5 million.
  • Avenue Therapeutics ATXI stock rose 16.34% to $1.21. The market value of their outstanding shares is at $6.6 million.
  • Ampio Pharmaceuticals AMPE stock moved upwards by 11.93% to $0.34. The market value of their outstanding shares is at $5.0 million.

Losers

  • OptimizeRx OPRX stock decreased by 18.4% to $13.25 during Thursday's pre-market session. The company's market cap stands at $227.2 million. The company's, Q4 earnings came out yesterday.
  • Landos Biopharma LABP shares decreased by 13.14% to $0.33. The market value of their outstanding shares is at $13.2 million.
  • Akebia Therapeutics AKBA shares decreased by 11.66% to $0.91. The company's market cap stands at $167.6 million. As per the press release, Q4 earnings came out today.
  • Fulcrum Therapeutics FULC shares decreased by 10.39% to $5.61. The company's market cap stands at $345.9 million. As per the press release, Q4 earnings came out today.
  • Ontrak OTRKP stock decreased by 9.2% to $0.79.
  • Novo Integrated Sciences NVOS shares fell 8.08% to $0.18. The company's market cap stands at $24.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...